These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35274632)

  • 1. An update on romiplostim for treatment of acute radiation syndrome.
    Singh VK; Seed TM
    Drugs Today (Barc); 2022 Mar; 58(3):133-145. PubMed ID: 35274632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on sargramostim for treatment of acute radiation syndrome.
    Singh VK; Seed TM
    Drugs Today (Barc); 2018 Nov; 54(11):679-693. PubMed ID: 30539167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romiplostim (Nplate
    Bunin DI; Bakke J; Green CE; Javitz HS; Fielden M; Chang PY
    Int J Radiat Biol; 2020 Jan; 96(1):145-154. PubMed ID: 31021662
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.
    Singh VK; Romaine PL; Newman VL; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1399-1408. PubMed ID: 27610458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.
    Singh VK; Newman VL; Seed TM
    Cytokine; 2015 Jan; 71(1):22-37. PubMed ID: 25215458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndrome.
    Yamaguchi M; Suzuki M; Funaba M; Chiba A; Kashiwakura I
    Stem Cell Res Ther; 2020 Aug; 11(1):339. PubMed ID: 32746943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
    Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
    Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filgrastim for the treatment of hematopoietic acute radiation syndrome.
    Farese AM; MacVittie TJ
    Drugs Today (Barc); 2015 Sep; 51(9):537-48. PubMed ID: 26488033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates.
    Wong K; Chang PY; Fielden M; Downey AM; Bunin D; Bakke J; Gahagen J; Iyer L; Doshi S; Wierzbicki W; Authier S
    Int J Radiat Biol; 2020 Jan; 96(1):155-166. PubMed ID: 31216213
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond.
    Singh VK; Seed TM
    Int J Radiat Biol; 2021; 97(11):1526-1547. PubMed ID: 34402734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celebrating 60 Years of Accomplishments of the Armed Forces Radiobiology Research Institute1.
    Bene BJ; Blakely WF; Burmeister DM; Cary L; Chhetri SJ; Davis CM; Ghosh SP; Holmes-Hampton GP; Iordanskiy S; Kalinich JF; Kiang JG; Kumar VP; Lowy RJ; Miller A; Naeem M; Schauer DA; Senchak L; Singh VK; Stewart AJ; Velazquez EM; Xiao M
    Radiat Res; 2021 Aug; 196(2):129-146. PubMed ID: 33979439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in medical countermeasure development against acute radiation exposure based on the US FDA animal rule.
    MacVittie TJ; Farese AM
    J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34433144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed renal injury in survivors of hematologic acute radiation syndrome.
    Gasperetti T; Frei A; Prasad Sharma G; Pierce L; Veley D; Szalewski N; Munjal Mehta S; Fish BL; Pleimes D; Himburg HA
    Int J Radiat Biol; 2023; 99(7):1130-1138. PubMed ID: 36688956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics as countermeasures for acute radiation syndrome: where are we now?
    Singh VK; Romaine PL; Newman VL
    Expert Opin Biol Ther; 2015 Apr; 15(4):465-71. PubMed ID: 25416452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thrombopoietin mimetic romiplostim leads to the complete rescue of mice exposed to lethal ionizing radiation.
    Yamaguchi M; Hirouchi T; Yokoyama K; Nishiyama A; Murakami S; Kashiwakura I
    Sci Rep; 2018 Jul; 8(1):10659. PubMed ID: 30006622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat Models of Partial-body Irradiation with Bone Marrow-sparing (Leg-out PBI) Designed for FDA Approval of Countermeasures for Mitigation of Acute and Delayed Injuries by Radiation.
    Fish BL; MacVittie TJ; Gao F; Narayanan J; Gasperetti T; Scholler D; Sheinin Y; Himburg HA; Hart B; Medhora M
    Health Phys; 2021 Oct; 121(4):419-433. PubMed ID: 34546222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of amifostine for the acute radiation syndrome.
    Singh VK; Seed TM
    Expert Opin Drug Saf; 2019 Nov; 18(11):1077-1090. PubMed ID: 31526195
    [No Abstract]   [Full Text] [Related]  

  • 20. Diverse functions of the thrombopoietin receptor agonist romiplostim rescue individuals exposed to lethal radiation.
    Yamaguchi M; Hirouchi T; Yoshioka H; Watanabe J; Kashiwakura I
    Free Radic Biol Med; 2019 May; 136():60-75. PubMed ID: 30926566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.